Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors.

MLA

Barbosa, Maria Letícia de Castro, et al. “Novel 2-Chloro-4-Anilino-Quinazoline Derivatives as EGFR and VEGFR-2 Dual Inhibitors.” European Journal of Medicinal Chemistry, vol. 71, Jan. 2014, pp. 1–14. EBSCOhost, https://doi.org/10.1016/j.ejmech.2013.10.058.

APA

Barbosa, M. L. de C., Lima, L. M., Tesch, R., Sant’Anna, C. M. R., Totzke, F., Kubbutat, M. H. G., Schächtele, C., Laufer, S. A., & Barreiro, E. J. (2014). Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors. European Journal of Medicinal Chemistry, 71, 1–14. https://doi.org/10.1016/j.ejmech.2013.10.058

Chicago

Barbosa, Maria Letícia de Castro, Lídia Moreira Lima, Roberta Tesch, Carlos Mauricio R Sant’Anna, Frank Totzke, Michael H G Kubbutat, Christoph Schächtele, Stefan A Laufer, and Eliezer J Barreiro. 2014. “Novel 2-Chloro-4-Anilino-Quinazoline Derivatives as EGFR and VEGFR-2 Dual Inhibitors.” European Journal of Medicinal Chemistry 71 (January): 1–14. doi:10.1016/j.ejmech.2013.10.058.